Fast Track Systems collaborates with Lilly to improve clinical trial process

Protocol Designer's structured Intelligent Clinical Protocol technology ensures coherent, complete, and consistent protocols that can be



Protocol Designer's structured Intelligent Clinical Protocol technology
ensures coherent, complete, and consistent protocols that can be
automatically benchmarked against industry best practices in a
collaborative design process. Studies completed in multiple large
pharmaceutical companies using Fast Track's approach have identified and
corrected operational issues that could have caused hundreds of thousands
of dollars of avoidable costs and months of delay.

"We're looking forward to a synergistic collaboration with Fast Track,"
said Stephen Ruberg, Ph.D., Director of Clinical Data Technology and
Services, Lilly. "We are interested in the unique combination of their
protocol design software and industry data. Our collaboration and these
tools could lead to improvements in many aspects of clinical trial design
and execution."

"According to a recent Datamonitor study, money spent by pharmaceutical
companies on R&D is increasing at a rate greater than the number of drugs
generated through such investment," said Jim McCord, CEO, Fast Track.
"Protocol Designer helps to reduce R&D costs overall by improving the
efficiency and effectiveness of the clinical trial process. We're
delighted to be working with an industry leader such as Lilly. With their
assistance, we expect to improve the industry's time and cost to market
for new drugs by enhancing the quality of the clinical trial design and
execution process."